Active Shortage

APO-TRAVOPROST-TIMOP PQ

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-TRAVOPROST-TIMOP PQ in Canada?

Yes. APO-TRAVOPROST-TIMOP PQ 0.5% 0.004% has an active shortage reported to Health Canada (last updated August 28, 2026).

Why is APO-TRAVOPROST-TIMOP PQ not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-TRAVOPROST-TIMOP PQ be available again?

The estimated resolution date (September 4, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist

StatusActive Shortage

Same-ingredient products on fileNone found

Affected strength0.5% 0.004%

Last updated2026-08-28

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

APO-TRAVOPROST-TIMOP PQ

APO-TRAVOPROST-TIMOP PQ: missing the documented justification for the results obtained.

Type II2025-12-17

Moderate health risk

Possible match — not confirmed

DIN

02415305

Strength

0.5% 0.004%

Dosage Form

SOLUTION

Route

OPHTHALMIC

Active Ingredient

TIMOLOL TRAVOPROST

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-08-28

Active Shortage

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244